Literature DB >> 33656892

Proteases and Their Modulators in Cancer Therapy: Challenges and Opportunities.

Rao Song1, Wenliang Qiao2, Jun He1, Jiasheng Huang1, Youfu Luo1, Tao Yang1,3.   

Abstract

Proteostasis is the process of regulating intracellular proteins to maintain the balance of the cell proteome, which is crucial for cancer cell survival. Several proteases located in the cytoplasm, mitochondria, lysosome, and extracellular environment have been identified as potential antitumor targets because of their involvement in proteostasis. Although the discovery of small-molecule inhibitors targeting proteases faces particular challenges, rapid advances in chemical biology and structural biology, and the new technology of drug discovery have facilitated the development of promising protease modulators. In this review, the protein structure and function of important tumor-related proteases and their inhibitors are presented. We also provide a prospective on advances and the outlook of new drug strategies that target these proteases.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33656892     DOI: 10.1021/acs.jmedchem.0c01640

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  4 in total

Review 1.  Fungal Proteases as Emerging Biocatalysts to Meet the Current Challenges and Recent Developments in Biomedical Therapies: An Updated Review.

Authors:  Muhammad Naeem; Saba Manzoor; Mashhud-Ul-Hasan Abid; Muhammad Burhan Khan Tareen; Mirza Asad; Sajida Mushtaq; Nazia Ehsan; Dua Amna; Baojun Xu; Abu Hazafa
Journal:  J Fungi (Basel)       Date:  2022-01-24

2.  Combined Cytotoxic Effect of Inhibitors of Proteostasis on Human Colon Cancer Cells.

Authors:  Alina D Nikotina; Snezhana A Vladimirova; Nadezhda E Kokoreva; Elena Y Komarova; Nikolay D Aksenov; Sergey Efremov; Elizaveta Leonova; Rostislav Pavlov; Viktor G Kartsev; Zhichao Zhang; Boris A Margulis; Irina V Guzhova
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-25

Review 3.  Review of potential medical treatments for middle ear cholesteatoma.

Authors:  Matthias Schürmann; Peter Goon; Holger Sudhoff
Journal:  Cell Commun Signal       Date:  2022-09-19       Impact factor: 7.525

4.  CST6 suppresses osteolytic bone disease in multiple myeloma by blocking osteoclast differentiation.

Authors:  Dongzheng Gai; Jin-Ran Chen; James P Stewart; Intawat Nookaew; Hasem Habelhah; Cody Ashby; Fumou Sun; Yan Cheng; Can Li; Hongwei Xu; Bailu Peng; Tarun K Garg; Carolina Schinke; Sharmilan Thanendrarajan; Maurizio Zangari; Fangping Chen; Bart Barlogie; Frits van Rhee; Guido Tricot; John D Shaughnessy; Fenghuang Zhan
Journal:  J Clin Invest       Date:  2022-09-15       Impact factor: 19.456

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.